• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过多维液相色谱和电喷雾串联质谱联用技术鉴定大肠杆菌细胞中(η6-芳烃)钌(II)蛋白结合位点:[(η6-对异丙基苯)RuCl2(DMSO)]与应激调节蛋白和螺旋酶的特异性结合

Identification of (eta6-arene)ruthenium(II) protein binding sites in E. coli cells by combined multidimensional liquid chromatography and ESI tandem mass spectrometry: specific binding of [(eta6-p-cymene)RuCl2 (DMSO)] to stress-regulated proteins and to helicases.

作者信息

Will Joanna, Kyas Andreas, Sheldrick William S, Wolters Dirk

机构信息

Lehrstuhl für Analytische Chemie, Ruhr-Universität Bochum, 44780 Bochum, Germany.

出版信息

J Biol Inorg Chem. 2007 Aug;12(6):883-94. doi: 10.1007/s00775-007-0242-x. Epub 2007 May 22.

DOI:10.1007/s00775-007-0242-x
PMID:17516097
Abstract

An automated multidimensional protein identification technology, which combines biphasic liquid chromatography with electrospray ionisation tandem mass spectrometry (MS/MS), was employed to analyse tryptic peptides from Escherichia coli cells treated with the antiproliferation agent [(eta(6)-p-cymene)RuCl(2)(DMSO)], where DMSO is dimethyl sulfoxide. MS/MS spectra were recorded for molecular ions generated by neutral loss of p-cymene from intensive peptide ions coordinated by the (eta(6)-p-cymene)Ru(II) fragment. Matching of the MS/MS spectra of the ruthenated peptides to spectra of proteins in the E. coli database enabled the identification of five protein targets for [(eta(6)-p-cymene)RuCl(2)(DMSO)]. One of these is the constitutive cold-shock protein cspC, which regulates the expression of genes encoding stress-response proteins, and three of the other targets, ppiD, osmY and sucC, are proteins of the latter type. The DNA damage-inducible helicase dinG was likewise established as a protein target. Aspartate carboxylate functions were identified as the probable Ru binding sites in cspC, ppiD and dinG, and threonine and lysine side chains in osmY and sucC, respectively.

摘要

采用一种自动多维蛋白质鉴定技术,该技术将双相液相色谱与电喷雾电离串联质谱(MS/MS)相结合,用于分析用抗增殖剂[(η⁶-对异丙基苯)RuCl₂(DMSO)]处理的大肠杆菌细胞中的胰蛋白酶肽,其中DMSO是二甲基亚砜。对由(η⁶-对异丙基苯)Ru(II)片段配位的强肽离子中性丢失对异丙基苯产生的分子离子记录MS/MS光谱。将钌化肽的MS/MS光谱与大肠杆菌数据库中的蛋白质光谱进行匹配,从而鉴定出[(η⁶-对异丙基苯)RuCl₂(DMSO)]的五个蛋白质靶点。其中之一是组成型冷休克蛋白cspC,它调节编码应激反应蛋白的基因的表达,其他三个靶点ppiD、osmY和sucC是后一种类型的蛋白质。DNA损伤诱导解旋酶dinG同样被确定为一个蛋白质靶点。分别确定天冬氨酸羧基官能团为cspC、ppiD和dinG中可能的Ru结合位点,苏氨酸和赖氨酸侧链分别为osmY和sucC中的Ru结合位点。

相似文献

1
Identification of (eta6-arene)ruthenium(II) protein binding sites in E. coli cells by combined multidimensional liquid chromatography and ESI tandem mass spectrometry: specific binding of [(eta6-p-cymene)RuCl2 (DMSO)] to stress-regulated proteins and to helicases.通过多维液相色谱和电喷雾串联质谱联用技术鉴定大肠杆菌细胞中(η6-芳烃)钌(II)蛋白结合位点:[(η6-对异丙基苯)RuCl2(DMSO)]与应激调节蛋白和螺旋酶的特异性结合
J Biol Inorg Chem. 2007 Aug;12(6):883-94. doi: 10.1007/s00775-007-0242-x. Epub 2007 May 22.
2
Characterisation of cisplatin coordination sites in cellular Escherichia coli DNA-binding proteins by combined biphasic liquid chromatography and ESI tandem mass spectrometry.通过双相液相色谱和电喷雾串联质谱联用技术对细胞内大肠杆菌DNA结合蛋白中顺铂配位位点的表征
J Biol Inorg Chem. 2008 Mar;13(3):421-34. doi: 10.1007/s00775-007-0333-8. Epub 2007 Dec 22.
3
Biomolecule binding vs. anticancer activity: reactions of Ru(arene)[(thio)pyr-(id)one] compounds with amino acids and proteins.生物分子结合与抗癌活性:钌(芳烃)[(硫代)吡啶酮]化合物与氨基酸和蛋白质的反应。
J Inorg Biochem. 2012 Mar;108:91-5. doi: 10.1016/j.jinorgbio.2011.08.011. Epub 2011 Aug 26.
4
Rapid identification of protein biomarkers of Escherichia coli O157:H7 by matrix-assisted laser desorption ionization-time-of-flight-time-of-flight mass spectrometry and top-down proteomics.基质辅助激光解吸电离飞行时间飞行时间质谱和自上而下蛋白质组学快速鉴定大肠杆菌 O157:H7 的蛋白质生物标志物。
Anal Chem. 2010 Apr 1;82(7):2717-25. doi: 10.1021/ac902455d.
5
Characterisation of cisplatin binding sites in human serum proteins using hyphenated multidimensional liquid chromatography and ESI tandem mass spectrometry.联用多维液相色谱和电喷雾串联质谱法对人血清蛋白中顺铂结合位点的表征
ChemMedChem. 2008 Nov;3(11):1696-707. doi: 10.1002/cmdc.200800151.
6
Quantification of bindings of organometallic ruthenium complexes to GSTπ by mass spectrometry.通过质谱法定量分析有机金属钌配合物与谷胱甘肽S-转移酶π的结合情况。
J Inorg Biochem. 2015 May;146:44-51. doi: 10.1016/j.jinorgbio.2015.02.015. Epub 2015 Mar 2.
7
Ruthenium(II) complexes containing bis(2-(diphenylphosphino)phenyl) ether and their catalytic activity in hydrogenation reactions.含双(2-(二苯基膦基)苯基)醚的钌(II)配合物及其在氢化反应中的催化活性。
Inorg Chem. 2007 Feb 5;46(3):809-17. doi: 10.1021/ic061782l.
8
Versatile coordination of acetazolamide to ruthenium(ii) p-cymene complexes and preliminary cytotoxicity studies.乙酰唑胺对钌(ii)对异丙基苯配合物的多功能配位作用及初步细胞毒性研究。
Dalton Trans. 2018 Jul 17;47(28):9367-9384. doi: 10.1039/c8dt01555d.
9
Enhanced identification of peptides lacking basic residues by LC-ESI-MS/MS analysis of singly charged peptides.通过 LC-ESI-MS/MS 分析单电荷肽增强对缺乏碱性残基的肽的鉴定。
Proteomics. 2012 May;12(9):1303-9. doi: 10.1002/pmic.201100569.
10
Water-soluble ruthenium(II) catalysts [RuCl2(eta6-arene)[P(CH2OH)3]] for isomerization of allylic alcohols and alkyne hydration.用于烯丙醇异构化和炔烃水合反应的水溶性钌(II)催化剂[RuCl2(η6-芳烃)[P(CH2OH)3]]
Dalton Trans. 2004 Nov 7(21):3635-41. doi: 10.1039/B411177J. Epub 2004 Oct 4.

引用本文的文献

1
The Protein-Binding Behavior of Platinum Anticancer Drugs in Blood Revealed by Mass Spectrometry.质谱法揭示铂类抗癌药物在血液中的蛋白质结合行为
Pharmaceuticals (Basel). 2021 Jan 29;14(2):104. doi: 10.3390/ph14020104.
2
Competitive binding sites of a ruthenium arene anticancer complex on oligonucleotides studied by mass spectrometry: ladder-sequencing versus top-down.质谱研究钌芳抗癌配合物在寡核苷酸上的竞争结合位点:梯式测序与自上而下。
J Am Soc Mass Spectrom. 2013 Mar;24(3):410-20. doi: 10.1007/s13361-012-0539-z. Epub 2013 Feb 13.
3
Sensitive Marker of the Cisplatin-DNA Interaction: X-Ray Photoelectron Spectroscopy of CL.

本文引用的文献

1
Diversity in guanine-selective DNA binding modes for an organometallic ruthenium arene complex.一种有机金属钌芳烃配合物对鸟嘌呤选择性DNA结合模式的多样性。
Angew Chem Int Ed Engl. 2006 Dec 11;45(48):8153-6. doi: 10.1002/anie.200602873.
2
Metal ion selectivity of oligopeptides.寡肽的金属离子选择性
Dalton Trans. 2006 Aug 28(32):3841-54. doi: 10.1039/b607515k. Epub 2006 Jul 17.
3
RNA helicases and abiotic stress.RNA解旋酶与非生物胁迫
顺铂-DNA 相互作用的敏感标记:CL 的 X 射线光电子能谱。
Bioinorg Chem Appl. 2012;2012:649640. doi: 10.1155/2012/649640. Epub 2012 Oct 24.
4
Reactivity of anticancer metallodrugs with serum proteins: new insights from size exclusion chromatography-ICP-MS and ESI-MS.抗癌金属药物与血清蛋白的反应性:尺寸排阻色谱-电感耦合等离子体质谱和电喷雾电离质谱的新见解
J Anal At Spectrom. 2010 Mar;25(3):305-313. doi: 10.1039/B922701F.
5
Organometallic anticancer compounds.有机金属抗癌化合物。
J Med Chem. 2011 Jan 13;54(1):3-25. doi: 10.1021/jm100020w. Epub 2010 Nov 15.
6
Reaction of the Anticancer Organometallic Ruthenium Compound, [(eta-p-Cymene)Ru(ATSC)Cl]PF(6) with Human Serum Albumin.抗癌有机金属钌化合物[(η-p-异丙基苯)Ru(ATSC)Cl]PF₆与人血清白蛋白的反应
Int J Inorg Chem. 2010 Jan 1;2010(975756):1-7. doi: 10.1155/2010/975756.
7
Exploring metallodrug-protein interactions by mass spectrometry: comparisons between platinum coordination complexes and an organometallic ruthenium compound.通过质谱法探索金属药物与蛋白质的相互作用:铂配位络合物与有机金属钌化合物的比较
J Biol Inorg Chem. 2009 Jun;14(5):761-70. doi: 10.1007/s00775-009-0489-5. Epub 2009 Mar 14.
8
Characterisation of cisplatin coordination sites in cellular Escherichia coli DNA-binding proteins by combined biphasic liquid chromatography and ESI tandem mass spectrometry.通过双相液相色谱和电喷雾串联质谱联用技术对细胞内大肠杆菌DNA结合蛋白中顺铂配位位点的表征
J Biol Inorg Chem. 2008 Mar;13(3):421-34. doi: 10.1007/s00775-007-0333-8. Epub 2007 Dec 22.
Nucleic Acids Res. 2006 Jun 21;34(11):3220-30. doi: 10.1093/nar/gkl408. Print 2006.
4
Functional conservation of cold shock domains in bacteria and higher plants.细菌和高等植物中冷休克结构域的功能保守性
Proc Natl Acad Sci U S A. 2006 Jun 27;103(26):10122-7. doi: 10.1073/pnas.0603168103. Epub 2006 Jun 20.
5
The role of cisplatin and NAMI-A plasma-protein interactions in relation to combination therapy.顺铂和NAMI-A与血浆蛋白的相互作用在联合治疗中的作用。
Int J Oncol. 2006 Jul;29(1):261-8.
6
Interactions of antitumor metallodrugs with serum proteins: advances in characterization using modern analytical methodology.抗肿瘤金属药物与血清蛋白的相互作用:运用现代分析方法进行表征的进展
Chem Rev. 2006 Jun;106(6):2224-48. doi: 10.1021/cr040704h.
7
The Escherichia coli proteome: past, present, and future prospects.大肠杆菌蛋白质组:过去、现在及未来展望
Microbiol Mol Biol Rev. 2006 Jun;70(2):362-439. doi: 10.1128/MMBR.00036-05.
8
In silico evolution of substrate selectivity: comparison of organometallic ruthenium complexes with the anticancer drug cisplatin.底物选择性的计算机模拟进化:有机金属钌配合物与抗癌药物顺铂的比较
Chem Commun (Camb). 2006 Jun 21(23):2451-3. doi: 10.1039/b601590e. Epub 2006 May 5.
9
Mechanisms of helicases.解旋酶的作用机制。
J Biol Chem. 2006 Jul 7;281(27):18265-8. doi: 10.1074/jbc.R600008200. Epub 2006 May 2.
10
Metal-based antitumour drugs in the post genomic era.后基因组时代的金属基抗肿瘤药物
Dalton Trans. 2006 Apr 28(16):1929-33. doi: 10.1039/b601840h. Epub 2006 Mar 28.